Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons

被引:152
作者
Southall, MD
Vasko, MR
机构
[1] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA
关键词
D O I
10.1074/jbc.M011408200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although a number of prostaglandin E-2 (PGE(2)) receptor subtypes have been cloned, limited studies have been performed to elucidate subtypes that subserve specific actions of this eicosanoid, in part because of a paucity of selective receptor antagonists. Using reverse transcription-polymerase chain reaction (PCR) and antisense oligonucleotides, we examined which prostaglandin E-2 receptor (EP receptor) subtypes are expressed in sensory neurons and which mediate the PGE(2)-induced increase in cAMP production and augmentation of peptide release. Reverse transcription-PCR of cDNA isolated from rat sensory neurons grown in culture revealed PCR products for the EP1, EP2, EP3C, and EP4 receptor subtypes but not the EP3A or EP3B. Preexposing neuronal cultures for 48 h to antisense oligonucleotides of EP3C and EP4 mRNA diminished expression of the respective receptors by similar to 80%, abolished the PGE(2)-stimulated production of cAMP, and blocked the ability of PGE(2) to augment release of immunoreactive substance P and calcitonin gene-related peptide. Pretreating with individual antisense against the EP2, EP3C, or EP4 receptors or combinations of missense oligonucleotides had no effect on PGE(2)-induced activity. Treatment with antisense to EPIC and EP4 receptor subtypes did not alter the ability of forskolin to increase cAMP or enhance peptide release. These results demonstrate that sensory neurons are capable of expressing multiple EP receptor subtypes but that only the EPIC and EP4 receptors mediate PGE(2)-induced sensitization of sensory neurons.
引用
收藏
页码:16083 / 16091
页数:9
相关论文
共 63 条
[1]   EFFECT OF BRADYKININ AND PROSTAGLANDINS ON THE RELEASE OF CALCITONIN GENE-RELATED PEPTIDE-LIKE IMMUNOREACTIVITY FROM THE RAT SPINAL-CORD INVITRO [J].
ANDREEVA, L ;
RANG, HP .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (01) :185-190
[2]   Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells - Structure and expression of the murine prostaglandin EP4 receptor gene [J].
Arakawa, T ;
Laneuville, O ;
Miller, CA ;
Lakkides, KM ;
Wingerd, BA ;
DeWitt, DL ;
Smith, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) :29569-29575
[3]   Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord [J].
Beiche, F ;
Klein, T ;
Nüsing, R ;
Neuhuber, W ;
Goppelt-Struebe, M .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 89 (1-2) :26-34
[4]   Nuclear localization of prostaglandin E2 receptors [J].
Bhattacharya, M ;
Peri, KG ;
Almazan, G ;
Ribeiro-Da-Silva, A ;
Shichi, H ;
Durocher, Y ;
Abramovitz, M ;
Hou, X ;
Varma, DR ;
Chemtob, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15792-15797
[5]   Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope [J].
Bhattacharya, M ;
Peri, K ;
Ribeiro-da-Silva, A ;
Almazan, G ;
Shichi, H ;
Hou, X ;
Varma, DR ;
Chemtob, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (22) :15719-15724
[6]   Exclusive expression of the Gs-linked prostaglandin E(2) receptor subtype 4 mRNA in human mononuclear Jurkat and KM-3 cells and coexpression of subtype 4 and 2 mRNA in U-937 cells [J].
Blaschke, V ;
Jungermann, K ;
Puschel, GP .
FEBS LETTERS, 1996, 394 (01) :39-43
[7]   Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes [J].
Boie, Y ;
Stocco, R ;
Sawyer, N ;
Slipetz, DM ;
Ungrin, MD ;
Neuschäfer-Rube, F ;
Püschel, GP ;
Metters, KM ;
Abramovitz, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 340 (2-3) :227-241
[8]   DESIGN AND APPLICATION OF ANTISENSE OLIGONUCLEOTIDES IN CELL-CULTURE, IN-VIVO, AND AS THERAPEUTIC AGENTS [J].
BRYSCH, W ;
SCHLINGENSIEPEN, KH .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 1994, 14 (05) :557-568
[9]  
Campbell W., 1996, Goodman and Gilman's the Pharmacological Basis of Therapeutics, Vninth, P601
[10]   ELIMINATION OF POTASSIUM CHANNEL EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES IN A PITUITARY CELL-LINE [J].
CHUNG, SW ;
SAAL, DB ;
KACZMAREK, LK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) :5955-5959